Table 2.
Controls (N = 34) | Periodontitis (N = 34) | CHD (N = 34) | Periodontitis+CHD (N = 34) | |
---|---|---|---|---|
N° of teeth | 25 (21; 27) | 19 (16; 18)** | 23 (20; 24)**,§§ | 18 (13; 21)**,## |
CAL (mm) | 1.1 (0.8; 1.5) | 3.7 (3.2; 4.1)** | 2.1 (1.9; 2.2)**,§§ | 3.8 (3.5; 4.6)**,## |
CAL 4–5 mm (% sites) | — | 38.7 (36.3; 41.8)** | — | 41.8 (36.5; 47)**,## |
CAL ≥6 mm (% sites) | — | 18.7 (18.2; 21.4)** | — | 17.9 (16.1; 23.8)**,## |
PD (mm) | 1.6 (1.2; 1.8) | 4.2 (3.9; 4.7)** | 2 (1.7; 2.2)**,§§ | 3.9 (3.7; 4.4)**,## |
PD 4–5 mm (% sites) | — | 41.4 (40.6; 44.7)** | — | 44.5 (41.3; 52.1)**,## |
PD ≥6 mm (% sites) | — | 21.3 (18.8; 23.1)** | — | 23.9 (21.2; 27.6)**,§§,## |
BOP (%) | 8.1 (6.1; 9.6) | 41.5 (35.4; 47.6)** | 8.5 (6.7; 8.4)**,§§ | 45.5 (42.6; 51.5)**,§§,## |
Rx alveolar bone loss (mm) | 0.2 (0.1; 0.4) | 2.9 (2.6; 3.5)** | 0.4 (0.2; 0.5)**,§§ | 3.4 (2.2; 4.2)**,## |
PI (%) | 6.7 (5; 9.5) | 36.6 (32.9; 34.6)** | 12.9 (10.1; 13.4)**,§§ | 31.6 (29.1; 35.4)**,## |
**p < 0.001 significant differences vs control subjects calculated by the Mann Whitney test. §§p < 0.001 significant differences vs periodontitis patients calculated by the Mann Whitney test. ##p < 0.001 significant differences vs CHD patients calculated by the Mann Whitney test.